Point72 Asia (Singapore) Pte. Ltd. Exact Sciences Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 792 shares of EXAS stock, worth $39,211. This represents 0.01% of its overall portfolio holdings.
Number of Shares
792Holding current value
$39,211% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$868 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$843 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$597 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$597 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$309 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.76B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...